Inhibrx Biosciences, Inc. (INBX)
78.30
+3.20
(+4.27%)
USD |
NASDAQ |
Jan 22, 10:58
Inhibrx Biosciences Market Cap: 1.134B for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 116.65M |
| Ligand Pharmaceuticals, Inc. | 4.059B |
| Armata Pharmaceuticals, Inc. | 217.25M |
| Adverum Biotechnologies, Inc. | 96.26M |
| Pelthos Therapeutics, Inc. | 15.47M |
Market Cap Related Metrics
| PS Ratio | 851.43 |
| Price to Book Value | 30.78 |
| Price | 78.30 |
| Earnings Yield | -13.07% |